The FDA has granted breakthrough therapy designation to SER-155 for the reduction of bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transplant.

These findings support the integration of PRO assessments into clinical decision-making and risk stratification in oncology,” the researchers concluded.

Researchers found the incidence of anal cancer is highest for cervical cancer survivors who are 65-75 years of age.

The FDA says it is taking new steps to eliminate misleading direct-to-consumer drug ads out of concern that patients are not receiving a "fair balance" of information on pharmaceutical products.

A history of moderate to severe traumatic brain injury is associated with an increased risk of malignant brain tumors, data suggest.

The FDA is moving to abandon a decades-old policy of asking advisory committees to review drug applications, and critics say the move could shield the agency's decisions from public scrutiny.

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.

It was difficult to determine the effect of bevacizumab on survival in this analysis because details on adjuvant therapy, maintenance therapy, and BRCA or HRD status were not available, the ...

Cancer Therapy Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

These results support the view that a considerable proportion of cancers arise from stochastic processes, rather than being solely driven by hereditary factors or environmental exposures,” the ...

(HealthDay News) — As many as 1 in 5 medical students in the United States may be food-insecure, according to a study published in JAMA Network Open.

Adding osimertinib to platinum-based chemotherapy may improve outcomes in patients with EGFR-mutant, advanced NSCLC who had disease progression on first-line osimertinib.